Skip to content
10-Q

Quarterly Report

VACCINOGEN INC

0001144204-15-031764

← back to feed
Filed
May 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 5, 2015 36.85M sh
Shares Diluted Q1 2015 · Mar 31, 2015 35.12M sh
Shares Diluted Q1 2015 · Mar 31, 2014 31.66M sh
Capex Q1 2015 · Mar 31, 2015 $61.77K
Capex Q1 2015 · Mar 31, 2014 $0
Cash And Equivalents Q1 2015 · Mar 31, 2015 $3.32M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $3.04M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $62.57K
Cash And Equivalents Q1 2015 · Dec 31, 2013 $73.1K
Stockholders Equity Q1 2015 · Mar 31, 2015 $49.99M
Stockholders Equity Q1 2015 · Dec 31, 2014 $52.88M
Current Liabilities Q1 2015 · Mar 31, 2015 $7.75M
Current Liabilities Q1 2015 · Dec 31, 2014 $5.54M
Total Liabilities Q1 2015 · Mar 31, 2015 $19.85M
Total Liabilities Q1 2015 · Dec 31, 2014 $18.21M
Current Assets Q1 2015 · Mar 31, 2015 $7.29M
Current Assets Q1 2015 · Dec 31, 2014 $6.09M
Total Assets Q1 2015 · Mar 31, 2015 $69.84M
Total Assets Q1 2015 · Dec 31, 2014 $71.08M
Eps Diluted Q1 2015 · Mar 31, 2015 −$0.20
Eps Diluted Q1 2015 · Mar 31, 2014 −$0.05
Eps Basic Q1 2015 · Mar 31, 2015 −$0.20
Eps Basic Q1 2015 · Mar 31, 2014 −$0.05
Sga Expense Q1 2015 · Mar 31, 2015 $1.91M
Sga Expense Q1 2015 · Mar 31, 2014 $707.93K
Rd Expense Q1 2015 · Mar 31, 2015 $2.96M
Rd Expense Q1 2015 · Mar 31, 2014 $2.02M
Net Income Q1 2015 · Mar 31, 2015 −$7.13M
Net Income Q1 2015 · Mar 31, 2014 −$1.68M
Operating Income Q1 2015 · Mar 31, 2015 −$4.87M
Operating Income Q1 2015 · Mar 31, 2014 −$2.73M
Revenue Q1 2015 · Mar 31, 2015 $0
Revenue Q1 2015 · Mar 31, 2014 $0